Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells.
Combination of phenethyl isothiocyanate (PEITC) and paclitaxel (taxol) has been shown to work synergistically to increase apoptosis and cell cycle arrest in breast cancer cells. In this report, we further explored the mechanisms for the synergistic activity of PEITC and taxol in MCF7 and MDA-MB-231 (MB) breast cancer cell lines. By Western blotting analysis, treatment of MCF7 cells with both PEITC and taxol led to a 10.4-fold and 5.96-fold increase in specific acetylation of alpha-tubulin over single agent PEITC and taxol, respectively. This synergistic effect on acetylation of alpha-tubulin was also seen in MB cells. The combination of PEITC and taxol also reduced expressions of cell cycle regulator Cdk1, and anti-apoptotic protein bcl-2, enhanced expression of Bax and cleavage of PARP proteins. In conclusion, this study provided biochemical evidence for the mechanism of synergistic effect between the epigenetic agent PEITC and the chemotherapeutic agent taxol.
Department of Oncology, Henan Province People's Hospital, Zhengzhou University, Zhengzhou, China.
Shundong
S
Cang
Department of Oncology, Henan Province People's Hospital, Zhengzhou University, Zhengzhou, China.
Yuehua
Y
Ma
Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA.
Jen-Wei
JW
Chiao
Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA.|Institute of Hematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, China.
Delong
D
Liu